ArticleScientific reports2016

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin.

Cao Xiaobo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.